Best BPC-157 Oral Supplements: ProHealth's Triple-Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026 36-Year Company's Oral Capsule Format vs. Injectable BPC-157: Third-Party Lab Testing, Bioavailability Questions, and Regulatory Status Examined GlobeNewswire December 23, 2025 CARPINTERIA, Dec. 23, 2025 (GLOBE NEWSWIRE) — This article contains affiliate links. If you purchase through […]

NEW YORK, NY / ACCESS Newswire / December 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation into Rezolute, Inc. ("Rezolute, Inc.") (NASDAQ:RZLT) concerning potential violations of the federal securities laws. On December 11, 2025, before the market opened, Rezolute announced topline results from its Phase 3 sunRIZE study evaluating

NEW YORK, NY / ACCESS Newswire / December 23, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (NYSE:AVTR) securities. If you suffered a loss on your Avantor, Inc. investment and would like to explore a potential

NEW YORK, NY / ACCESS Newswire / December 23, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Perrigo Company plc (NYSE:PRGO) securities. If you suffered a loss on your Perrigo Company plc investment and would like to explore

NEW YORK, NY / ACCESS Newswire / December 23, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Firefly Aerospace Inc. (NASDAQ:FLY) securities. If you suffered a loss on your Firefly Aerospace Inc. investment and would like to explore

NEW YORK, NY / ACCESS Newswire / December 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fermi Inc. ("Fermi" or the "Company") (NASDAQ:FRMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fermi and certain of its officers and/or directors have

NEW YORK CITY, NY / ACCESS Newswire / December 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Galectin Therapeutics Inc. ("Galectin" or the "Company") (NASDAQ:GALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Galectin and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / December 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation ("Xoma" or the "Company") (NASDAQ:XOMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Xoma and certain of its officers and/or

NEW YORK, NY / ACCESS Newswire / December 23, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Integer Holdings Corporation (NYSE:ITGR) securities. If you suffered a loss on your Integer Holdings Corporation investment and would like to explore

NEW YORK CITY, NY / ACCESS Newswire / December 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC Therapeutics" or the "Company") (NYSE:ADCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ADC Therapeutics and certain of its